Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping.

× No keyword cloud information.

13 in total

1. Commentary: a physiological approach to hepatic drug clearance.

Authors: G R Wilkinson; D G Shand
Journal: Clin Pharmacol Ther Date: 1975-10 Impact factor: 6.875

2. An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity.

Authors: Janyce F Rogers; Mario L Rocci; David B Haughey; Joseph S Bertino
Journal: Clin Pharmacol Ther Date: 2003-03 Impact factor: 6.875

3. Chronopharmacokinetic study with prolonged infusion of midazolam.

Authors: U Klotz; I W Reimann
Journal: Clin Pharmacokinet Date: 1984 Sep-Oct Impact factor: 6.447

4. Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.

Authors: C K Svensson; D J Edwards; P M Mauriello; S H Barde; A C Foster; R A Lanc; E Middleton; D Lalka
Journal: Clin Pharmacol Ther Date: 1983-09 Impact factor: 6.875

5. Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.

Authors: J L Fayer; P N Zannikos; J C Stevens; Y Luo; R Sidhu; S Kirkesseli
Journal: J Clin Pharmacol Date: 2001-03 Impact factor: 3.126

6. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.

Authors: C Wandel; J S Witte; J M Hall; C M Stein; A J Wood; G R Wilkinson
Journal: Clin Pharmacol Ther Date: 2000-07 Impact factor: 6.875

1. Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotyping.

Authors: Joanna C Masters; Denise M Harano; Howard E Greenberg; Shirley M Tsunoda; In-Jin Jang; Joseph D Ma
Journal: Ther Drug Monit Date: 2015-02 Impact factor: 3.681

1 in total

Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping.

1. Commentary: a physiological approach to hepatic drug clearance.

2. An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity.

3. Chronopharmacokinetic study with prolonged infusion of midazolam.

4. Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.

5. Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.

6. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.

7. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.

8. Physiological and pharmacological variability in estimated hepatic blood flow in man.

9. Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow.

Review 10. Influence of posture on pharmacokinetics.

1. Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotyping.